Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 233

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 19
Chunk 233
---
ITEM 19. EXHIBITS.

  Exhibit No.      Exhibit                                                                                                                                                                                               
                   Description                                                                                                                                                                                           
          2.1      Description of Securities (included as Exhibit 2.1 to our Annual Report on Form 20-F as filed with the Securities Exchange Commission on January 29, 2024, and incorporated herein by reference).     
          4.1      Form of Underwriter’s Warrant (included as Exhibit 4.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on November 14, 2022, and incorporated here...  
          4.2      Form of Indemnification Agreement (included as Exhibit 10.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on November 14, 2022, and incorporated...  
          4.3      Omnibus Stock Award Plan (included as Exhibit 99.1 to our Registration Statement on FormS-8 as filed with the Securities Exchange Commission on December 9, 2024, and incorporated herein by refe...  
          4.4      SciSparc Cooperation Agreement (included as Exhibit 10.7 to our Registration Statement on Form F-1 as filed with the Securities Exchange Commission on November 14, 2022, and incorporated herein...  
          4.5      Form of Placement Agent Agreement by and between the Company and Aegis Capital Corp (included as Exhibit 1.1 to our Report on Form 6-K as filed with the Securities Exchange Commission on April ...  
          4.6      Form of Common Warrant (included as Exhibit 4.2 to our Registration Statement on Form F-1 as filed with the Securities Exchange Commission on March 30, 2023, and incorporated herein by reference).  
          4.7      Form of Pre-Funded Warrant (included as Exhibit 4.1 to our Registration Statement on Form F-1 as filed with the Securities Exchange Commission on March 30, 2023, and incorporated herein by refe...  
          4.8      Form of Warrant Agent Agreement (included as Exhibit 4.3 to our Registration Statement on Form F-1 as filed with the Securities Exchange Commission on March 27, 2023, and incorporated herein by...  
          4.9      Form of Placement Agent Agreement by and between the Company and Aegis Capital Corp (included as Exhibit 1.1 to our